Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Recent papers from Robert H. Lurie Comprehensive Cancer Center of Northwestern University

1. Macrophage immunometabolism in glioblastoma: from microglial reprogramming to B cell dysfunctionFrontiers in Immunology · 2026
2. Optimizing adolescent inguinal hernia repair: a comprehensive robotic-assisted laparoscopic approachHernia · 2026
3. Head and neck cancer in older adults: biological aging, treatment tolerance, and survivorshipJNCI Journal of the National Cancer Institute · 2026
4. COMPANION-002: A Randomized Phase 2/3 Trial of Tovecimig Plus Paclitaxel versus Paclitaxel Alone as a Second-line Therapy in Patients with Advanced Biliary Tract CancerJournal of Clinical Oncology · 2026
5. Navigating T-Cell-Directed Therapies in Transformed Follicular LymphomaCancers · 2026
6. Continuous Pulse Oximetry Analysis to Predict Outcomes in Young Infants With Bronchiolitis Presenting to the Emergency DepartmentPediatric Emergency Care · 2026
7. Supradiaphragmatic Epicardial Pacemaker Implantation for Pseudo-Atrioventricular Block in Neonatal Long QT Syndrome: Genotype-Agnostic Anesthetic Strategy Pending Genetic DiagnosisJournal of Cardiothoracic and Vascular Anesthesia · 2026
8. Coordinated inhibition of SOX9 and cell-cycle progression by microRNA-200 restricts sebaceous gland fate specificationNature Communications · 2026
9. The Association of Late-Onset Hyponatremia with Feeding Type in Preterm Infants: A Retrospective StudyChildren · 2026
10. Human myometrial cell fate under chronic oxidative stress for leiomyomagenesisScientific Reports · 2026
11. Improving survival in molecularly selected glioblastomaThe Lancet · 2019
12. Two Mechanistic Pathways for Thienopyridine-Associated Thrombotic Thrombocytopenic PurpuraJournal of the American College of Cardiology · 2007
13. SETDB1 preferentially silences evolutionarily young retroelementsProceedings of the National Academy of Sciences · 2026
14. Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate CancerJournal of Clinical Oncology · 2026
15. Summary of Research: Health-Related Quality-of-Life Profile and Clinical Outcomes in First-Line Advanced Renal Cell Carcinoma: A Modeling Analysis Based on the CheckMate 9ER StudyAdvances in Therapy · 2026
16. An international multicenter analysis of the outcome of pediatric first variceal hemorrhageHepatology · 2026
17. Genomic drivers of leukemia and blinatumomab response in adult acute lymphoblastic leukemia - the ECOG-ACRIN E1910 studyBlood · 2026
18. An evidence-based workflow for integrating molecular testing with histopathology in the workup of meningiomasNeuro-Oncology · 2026
19. Plasma nucleosome profiling reports on tumor burden and molecular subtypes in small cell lung cancerJournal of Clinical Investigation · 2026
20. Giredestrant plus Everolimus in Advanced Breast CancerNew England Journal of Medicine · 2026